Protagonist Therapeutics Inc (PTGX)

Number of days of payables

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Payables turnover		11.35	43.38	25.62	6.85	7.42	8.72	6.86	23.17	4.43	17.00	35.31	2.85	7.33	6.06	6.35	5.91	4.47	5.64	9.58	5.20
Number of days of payables	days	32.17	8.41	14.25	53.31	49.20	41.86	53.17	15.75	82.31	21.47	10.34	127.87	49.79	60.22	57.51	61.75	81.64	64.66	38.12	70.13

March 31, 2024 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 11.35
= 32.17

Protagonist Therapeutics Inc's number of days of payables has fluctuated over the past few quarters. On March 31, 2024, the company took approximately 32.17 days to pay its payables, reflecting a relatively stable payment timeline compared to the previous quarter. In the December and September quarters of 2023, the number of days of payables was significantly lower at 8.41 days and 14.25 days respectively, indicating that the company was able to manage its payables more efficiently during those periods.

In contrast, the company took longer to pay its obligations in the June and March quarters of 2023, with 53.31 days and 49.20 days respectively. This suggests a delayed payment cycle during those periods compared to the more efficient payment patterns seen in the previous quarters. Notably, in the December 2022 quarter, the number of days of payables was relatively high at 41.86 days, indicating a potential strain on the company's cash flow management.

Overall, Protagonist Therapeutics Inc's number of days of payables has shown variability, with some quarters reflecting more efficient payment practices and others demonstrating longer payment periods. It is important for the company to closely monitor and manage its payables to ensure optimal cash flow management and financial health.